At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 200 enrolled
Drug / intervention
TRV130 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Placebo- and Active-controlled Study of TRV130 for the Treatment of Acute Postoperative Pain Following Abdominoplasty
In Brief
A Phase 2 clinical trial evaluating TRV130, Morphine, and 1 other intervention for Pain. Completed, enrolled 200 participants across 2 sites.
Detailed Summary
The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsLotus Clinical Research, LLC
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedJan 2015
Primary CompletionJul 2015
Study CompletionAug 2015
TodayJul 2026
First PostedJan 9, 2015
Enrollment StartDec 1, 2014
Primary CompletionJul 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.5 years ago
Interventions
TRV130drug
Rescue: Ibuprofen, oxycodone
Morphinedrug
Rescue: Ibuprofen, oxycodone
Placebodrug
Rescue: Ibuprofen, oxycodone